Opioids in geriatric units in 14 Belgian hospitals: prevalence, dosage and associated factors
Open Access
- 31 January 2024
- journal article
- research article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 56 (1) , 2310132
Abstract
Introduction: Adverse effects of opioids are common among older individuals, and undertreatment as well as overuse can be an issue. Epidemiological data on opioid use in older individuals are available, but scarce in hospitalized patients.Aims: The aim of this study is to examine the one-day prevalence of opioid use among older inpatients and identify the factors associated with both opioid use and dosage.Materials and methods: One-day cross-sectional study with data collected from geriatric units across 14 Belgian hospitals. The primary focus of the study is to assess the prevalence of opioid use and dosage, along with identifying associated factors. To achieve this, a multiple binary logistic regression model was fitted for opioid use, and a multiple linear regression model for opioid dose.Results: Opioids were used in 24.4% of 784 patients, of which 57.9% was treated with tramadol, 13.2% with oxycodone or morphine and 28.9% with transdermal buprenorphine or fentanyl. The odds for opioid use were 4.2 times higher in patients in orthogeriatric units compared to other patients (OR=4.2, 95% CI=2.50-7.05). The prevalence of opioid use was 34% higher in patients without dementia compared to patients with dementia (OR=0.66, 95% CI=0.46-0.95). The overall mean daily dosage was 14.07mg subcutaneous morphine equivalent. After adjustment for age, gender and dementia, dosage was only associated with type of opioid: the estimated mean opioid dose was 70% lower with tramadol (mean ratio=0,30,95% CI=0,23-0,39) and 67% lower with oxycodone and morphine (mean ratio=0,33, 95% CI=0,22-0,48) compared to transdermal buprenorphine and transdermal fentanyl.Conclusions: One in four patients received opioid treatment. It is not clear whether this reflects under- or overtreatment, but these results can serve as a benchmark for geriatric units to guide future pain management practices. The utilization of transdermal fentanyl and buprenorphine, resulting in higher doses of morphine equivalent, poses significant risks for side effects.Keywords
This publication has 68 references indexed in Scilit:
- Guidance on the management of pain in older peopleAge and Ageing, 2013
- A merican G eriatrics S ociety Updated B eers C riteria for Potentially Inappropriate Medication Use in Older AdultsJournal of the American Geriatrics Society, 2012
- Adverse Effects Associated with Non-opioid and Opioid Treatment in Patients with Chronic PainClinical Drug Investigation, 2012
- Pain Treatment in Elderly Persons With and Without DementiaDrugs & Aging, 2011
- Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairmentBritish Journal of Clinical Pharmacology, 2011
- Outcomes Associated with Opioid Use in the Treatment of Chronic Noncancer Pain in Older Adults: A Systematic Review and Meta‐AnalysisJournal of the American Geriatrics Society, 2010
- Chronic Musculoskeletal Pain and the Occurrence of Falls in an Older PopulationJAMA, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone)Pain Practice, 2008
- Disparities in Pain Management Between Cognitively Intact and Cognitively Impaired Nursing Home ResidentsJournal of Pain and Symptom Management, 2008